Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real‐life study (DUPIREAL)
Eugenio De Corso, Ernesto Pasquini, Matteo Trimarchi, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2669-2683
Open Access | Times Cited: 77

Showing 26-50 of 77 citing articles:

Olfactory impairment in Italian patients with chronic rhinosinusitis with nasal polyps: a patient-centered survey
Francesca Anastasi, Frank Rikki Canevari, Stefania Gallo, et al.
Frontiers in Allergy (2025) Vol. 5
Open Access
Eosinophilic esophagitis in the “atopic march”: dupilumab as an “umbrella” strategy for multiple coexisting atopic diseases
Nicola Lutzu, Agnese Favale, M. Demurtas, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Biological therapy in Chronic rhinosinusitis with nasal polyps
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal polyps
Angélica Tiotiu, Nicolas Migueres, Francisco Javier González‐Barcala, et al.
Respiratory Medicine (2025) Vol. 238, pp. 107979-107979
Closed Access
Almost Half of the Dupilumab‐Treated Patients With Severe CRS With Nasal Polyps Achieve Remission in One Year
Josje Janna Otten, Hester Beatrice Emilie Elzinga, Rik Johannes Leonardus van der Lans, et al.
Allergy (2025)
Open Access
Dupilumab in the Treatment of Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Comorbid Asthma—A Multidisciplinary Monocentric Real-Life Study
Gian Luca Fadda, Cecilia Rustichelli, Simone Soccal, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 501-501
Open Access
Clinical effectiveness of dupilumab in CRSwNP: unaffected by baseline nasal polyp size in real-world settings
Michael Habenbacher, Ulrich Moser, Ahmed Abaira, et al.
European Archives of Oto-Rhino-Laryngology (2025)
Open Access
A real-life evaluation of SNOT-22 domains in a cohort of CRSwNP patients treated with biologic therapies for 12 months
Giulia Costanzo, Andrea Ledda, Giada Sambugaro, et al.
World Allergy Organization Journal (2025) Vol. 18, Iss. 3, pp. 101041-101041
Open Access
Impact of single versus multiple surgeries in CRSwNP patients undergoing treatment with dupilumab
Matteo Alicandri‐Ciufelli, Carla Cantaffa, Costanza Galloni, et al.
Acta Oto-Laryngologica (2025), pp. 1-7
Closed Access
Dupilumab Monthly Dose De‐Escalation Maintains Efficacy in CRSwNP: A Two‐Year Real‐World Study
Eugenio De Corso, Claudio Montuori, Gabriele De Maio, et al.
The Laryngoscope (2025)
Open Access
Diagnostik und medikamentöse Therapie der chronischen Rhinosinusitis
Sven Becker
HNO (2025)
Open Access
Sustained Efficacy and Low Rate of Adverse Events of Dupilumab in Type‐2 CRSwNP Over 48 Months
Pietro Orlando, Giuseppe Licci, Gennaro Illiano, et al.
The Laryngoscope (2025)
Closed Access
Dupilumab's impact on nasal citology: Real life experience after 1 year of treatment
Matteo Gelardi, Rossana Giancaspro, Vitaliano Nicola Quaranta, et al.
American Journal of Otolaryngology (2024) Vol. 45, Iss. 4, pp. 104275-104275
Open Access | Times Cited: 3
Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma
Tomoko Tajiri, Motohiko Suzuki, Hirono Nishiyama, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 5, pp. 550-558.e2
Closed Access | Times Cited: 3
Rheumatic adverse events associated with biologic therapy for chronic rhinosinusitis: A systematic review and meta‐analysis
Jenny B. Xiao, Helen Hsiao, Carlos Khalil, et al.
International Forum of Allergy & Rhinology (2024) Vol. 14, Iss. 10, pp. 1618-1633
Open Access | Times Cited: 3
'Efficacy of biologics in NSAID-ERD: United airways from the nose to the bronchi'
Kathleen M. Buchheit, Elke Vandewalle, Hester Beatrice Emilie Elzinga, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2917-2932
Closed Access | Times Cited: 3
The IL‐4–IL‐4Rα axis modulates olfactory neuroimmune signaling to induce loss of smell
Yannis Hara, Mithilesh Kumar Jha, Jeremy Huang, et al.
Allergy (2024) Vol. 80, Iss. 2, pp. 440-461
Open Access | Times Cited: 3
Asthma Phenotypes in the Era of Personalized Medicine
Víctor González-Uribe, Sergio Jesús Romero-Tapia, José A. Castro‐Rodríguez
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6207-6207
Open Access | Times Cited: 7
Endoscopic Extended Sinus Surgery for Patients with Severe Chronic Rhinosinusitis with Nasal Polyps, the Choice of Mucoplasty: A Systematic Review
Daniel Martín-Jiménez, Ramón Moreno‐Luna, A del Cuvillo, et al.
Current Allergy and Asthma Reports (2023) Vol. 23, Iss. 12, pp. 733-746
Open Access | Times Cited: 7
Diagnostics of allergic rhinitis under dupilumab therapy
Patrick Huber, Moritz Gröger, Clemens Stihl, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 8, pp. 4183-4190
Open Access | Times Cited: 2
Pre-asthma: a useful concept? A EUFOREA paper. Part 2—late onset eosinophilic asthma
Glenis Scadding, Claudia L. Gray, Diego M. Conti, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access | Times Cited: 2
Dupilumab: a delayed response in asthmatic and atopic patients treated for chronic rhinosinusitis with nasal polyps
Umberto Tanzini, Andrea Rampi, Alessandro Vinciguerra, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 10, pp. 5285-5292
Open Access | Times Cited: 2
Clinical Effects and Response Time of Biological Drugs in Chronic Rhinosinusitis with Nasal Polyps Patients: Real‐life Experience
S. De Santis, Stefania Galassi, Jacopo Cambi
The Laryngoscope (2024)
Closed Access | Times Cited: 2
Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study
Eugenio De Corso, Claudio Montuori, Silvia Baroni, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 281, Iss. 5, pp. 2429-2440
Closed Access | Times Cited: 6
Dupilumab in chronic rhinosinusitis with nasal polyposis: current status, challenges, and future perspectives
Tong Li, Jiali Yin, Yujuan Yang, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 8, pp. 939-948
Closed Access | Times Cited: 5

Scroll to top